PINELABS172.71

Pine Labs Ltd.

· Banking & Finance
₹ CrorePeersPAYTMNUVAMASTARHEALTHJMFINANCILUCOBANKIOBIFCIAADHARHFCMcap ₹19,832 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
PINELABS
FY26
PAYTM
FY26
NUVAMA
FY26
STARHEALTH
FY26
Peer
Median
Valuation — at last close
P/E164.49×199.21×30.53×114.87× +43%
P/B3.36×6.89×7.76×7.33× -54%
EV/EBITDA52.23×210.28×210.28× -75%
Market Cap₹19,832 Cr₹1.10L Cr₹32,004 Cr₹71,209 Cr -72%
Growth
Revenue CAGR 3Y1.83%27.87%14.85%
Net Income CAGR 3Y50.52%50.52%
Revenue YoY (latest Q)27.67%22.59%25.13%
Net Income YoY (latest Q)79.59%15.83%47.71%
Profitability
EBITDA Margin13.23%5.95%52.72%29.34% -55%
Net Income Margin4.15%6.54%22.46%14.50% -71%
Return on Common Equity1.91%3.45%25.25%14.35% -87%
Return on Capital Employed1.45%-0.40%-0.40% +463%
Return on Assets0.85%2.31%3.02%2.67% -68%
Credit & Quality
Total Debt/Equity0.05×0.00×0.00×
Interest Coverage1.05×-3.67×2.38×-0.65× +263%
Scale — latest FY
Revenue / Total Income₹2,711 Cr₹8,437 Cr₹4,631 Cr₹6,534 Cr -59%
Net Income₹113 Cr₹552 Cr₹1,040 Cr₹796 Cr -86%
Total Assets₹13,297 Cr₹23,915 Cr₹34,491 Cr₹29,203 Cr -54%
EPS₹1.05₹8.66₹57.59₹33.13 -97%
Book Value per Share₹51.34₹250.44₹226.48₹238.46 -78%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.